Telemedicine technologies in the profile of «Pediatric oncology», «Hematology», «Immunology» within the framework of the project «Development of the NMRC network».

Telemedicine technologies are an indispensable tool in pediatric oncology, hematology and immunology. They improve the availability, quality and effectiveness of medical care, enhance the quality of life of patients and their families, and optimize the use of healthcare resources. Further development and implementation of telemedicine technologies in these areas of medicine is a priority task aimed at improving treatment outcomes and increasing the survival rate of children with these complex diseases. Purpose of the study was to evaluate the effectiveness of the use of telemedicine technologies by the Dmitry Rogachev National Medical Research Center for Pediatric Hematology and Immunology of the Ministry of Health of the Russian Federation within the framework of the Federal Project «Development of the NMRC Network» (2019–2024) to improve the provision of medical care to children with oncological, hematological and immunological diseases in the constituent entities of the Russian Federation. Materials and methods. The data of more than 72 thousand telemedicine consultations conducted by the telemedicine center of the Dmitry Rogachev National Medical Research Center for Pediatric Hematology and Immunology were analyzed. Dmitry Rogachev National Medical Research Center for Pediatric Hematology and Oncology of the Ministry of Health of the Russian Federation with third-level medical organizations in the constituent entities of the Russian Federation in the period from 2019 to 2024. The distribution of consultation profiles and diagnoses by region, as well as the frequency of hospitalizations and the need for reference studies were assessed. Results. Telemedicine consultations have proven highly effective in treating children with oncological, hematological and immunological diseases. Remote consultations made it possible to overcome geographical limitations, a shortage of qualified specialists and reduce the time before treatment, which is critically important for this category of patients. Conclusions. The use of telemedicine technologies by the Dmitry Rogachev National Medical Research Center for Pediatric Hematology and Oncology of the Ministry of Health of the Russian Federation within the framework of the Federal Project «Development of the NMRC Network» helps to increase the availability and quality of medical care for children with oncological, hematological and immunological diseases in the constituent entities of the Russian Federation, optimizes the clinical decision-making process and reduces the time before treatment.